|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) tumor necrosis factor receptor superfamily, member 17 DNA.|
|Identical with XM_001093265.1 [ Macaca mulatta (Rhesus monkey) ]: 165 C/A not causing the amino acid variation. Please check the sequence information before order.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Cynomolgus monkey TNFRSF17 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||CG90103-G-F|
|Cynomolgus monkey TNFRSF17 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||CG90103-G-H|
|Cynomolgus monkey TNFRSF17 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||CG90103-G-M|
|Cynomolgus monkey TNFRSF17 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||CG90103-G-N|
|Cynomolgus monkey TNFRSF17 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||CG90103-G-Y|
|Product name||Product name|
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13BBAFF), and to lead to NF-kappaB and MAPK8/JNK activation. TNFRSF17/BCMA/CD269 also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. TNFRSF17/BCMA/CD269 is a receptor for TALL-1 and BCMA activates NF-kappaB through a TRAF5-, TRAF6-, NIK-, and IKK-dependent pathway. The identification of TNFRSF17 as a NF-kappaB-activating receptor for TALL-1 suggests molecular targets for drug development against certain immunodeficient or autoimmune diseases. TNFRSF17/BCMA is a target of donor B-cell immunity in patients with myeloma who respond to DLI. Antibody responses to cell-surface BCMA may contribute directly to tumor rejection in vivo.